Non sedating allergy medicine women decide dating
Fertility Systemic administration of acrivastine in animal reproductive studies did not produce embryotoxic or teratogenic effects and did not impair fertility.
Pregnancy There are no adequate and well-controlled studies in pregnant women.
ATC code: R06AX18 Acrivastine provides symptomatic relief in conditions believed to depend wholly or partly upon the triggered release of histamine.
Acrivastine is a competitive H1 receptor antagonist chemically related to triprolidine.
However, due to known interactions between these compounds and other non-sedating antihistamines, caution is advised.
Pharmacotherapeutic group: Other antihistamines for systemic use.
When the recommended therapeutic dose has been exceeded, acrivastine has been found to impair the ability to drive.
This effect is related to the amount of acrivastine taken beyond the recommended maximum daily dosage.
Posology Adults and children 12 years – 65 years: One 8 mg capsule, as necessary up to three times a day.
Elderly As yet, no specific studies have been carried out in the elderly.